Pain
Conditions
Interventions
GroupT:0.2% Ropivacaine + NS, total 40 ml
GroupE:0.2% Ropivacaine+ 0.5 mg/kg Esketamine+ NS, total 40 ml
Sponsors
Chengdu Integrated TCM&Western Medicine Hospital (Chengdu first people's Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age: 18 - 65 years old, gender not restricted, BMI: 18 - 30 Kg/m^2, ASA classification: II - III. 2. Patients who have undergone single-port laparoscopic surgery. 3. Clearly understand and voluntarily participate in this study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. BMI > 30 kg/m^2 ; 2. Those who are allergic or contraindicated to the main experimental drug components; 3. Those with uncontrolled severe heart, lung, liver or kidney diseases; 4. Those with a history of abdominal wall surgery, coagulation dysfunction, or skin infections; 5. Patients currently participating in other clinical trials or those who, in the opinion of the researchers, are not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale score;Pittsburgh Sleep Quality Index Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| White blood cell;Systemic Inflammatory Immune Index; | — |
Countries
China
Contacts
Public ContactZuofeng Wang
Chengdu Integrated TCM&Western Medicine Hospital (Chengdu first people's Hospital)
Outcome results
None listed